**Question:** All are true about anaplastic carcinoma thyroid, except:

A. Anaplastic carcinoma is a rare form of thyroid cancer with a very aggressive course.
B. Anaplastic carcinoma usually presents with a rapidly growing mass in the neck.
C. Anaplastic carcinoma is often difficult to differentiate from other aggressive tumors like teratoma or sarcoma.
D. Anaplastic carcinoma has a tendency to spread to regional lymph nodes.

**Correct Answer:** C. Anaplastic carcinoma is often difficult to differentiate from other aggressive tumors like teratoma or sarcoma.

**Core Concept:** Anaplastic carcinoma thyroid (ACT) is a rare and highly aggressive form of thyroid cancer, accounting for less than 1% of all thyroid cancers. Unlike well-differentiated thyroid cancer (WDTC), which usually presents with a long-standing history of a slow-growing, palpable mass in the neck, ACT often presents with a rapid growth and may be difficult to differentiate from other aggressive tumors like teratoma or sarcoma on clinical examination alone.

**Why the Correct Answer is Right:** The correct answer is option C because, despite being a thyroid cancer, ACT is often challenging to differentiate from other aggressive tumors like teratoma or sarcoma due to the rapid growth and aggressive nature of the tumor. While WDTC typically presents with a slow-growing, long-standing mass, ACT can manifest similarly due to its aggressive nature, making accurate differentiation difficult without further diagnostic tools and investigations.

**Why Each Wrong Option is Incorrect:**

A. Although anaplastic carcinoma is indeed a rare form of thyroid cancer, this option is incorrect because all other options are true statements about the disease.

B. While anaplastic carcinoma does present as a rapidly growing mass in the neck, this option is incorrect because it does not address the difficulty of differentiation from other aggressive tumors.

D. Although anaplastic carcinoma is known to spread to regional lymph nodes, this option is incorrect because option C addresses the challenge of differentiating the tumor from other aggressive tumors due to its aggressive nature and rapid growth.

**Clinical Pearl:** To accurately diagnose and differentiate ACT from other aggressive tumors, a combination of clinical examination, imaging studies (CT/MRI/PET-CT), fine-needle aspiration cytology (FNAC), and, if necessary, histopathological examination (HPE) of the tumor are essential. This ensures a comprehensive evaluation of the tumor's nature, growth rate, and potential to infiltrate neighboring structures and spread to regional lymph nodes. Additionally, considering the rapidly growing nature and aggressive behavior of ACT, it is crucial to rule out other aggressive tumors like teratoma and sarcoma by using the mentioned diagnostic tools.